Insulin resistance and pancreatic β cell failure

Journal of Clinical Investigation

Volumn 116, Issue 7, 2006, Pages 1756-1760

  Kasuga, Masato ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ATHEROSCLEROSIS; CELL DAMAGE; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; HUMAN; INSULIN RESISTANCE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PANCREAS ISLET BETA CELL; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

ATHEROSCLEROSIS; DIABETES MELLITUS, TYPE 2; HUMANS; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; OBESITY;

EID: 33745851096     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI29189     Document Type: Review

References (47)

1. Anderson, J.W., Kendall, C.W., and Jenkins, D.J. 2003. Importance of weight management in type 2 diabetes: review with meta-analysis of clinical studies. J. Am. Coll. Nutr. 22:331-339.
2. Shepherd, P.R., Withers, D.J., and Siddle, K. 1998. Phosphoinositide 3-kinase: the key switch mechanism in insulin signaling. Biochem. J. 333:471-490.
3. Michael, M.D., et al. 2000. Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol. Cell. 6:87-94.
4. Miyake, K., et al. 2002. Hyperinsulinemia, glucose intolerance, and dyslipidemia induced by acute inhibition of phosphoinositide 3-kinase signaling in the liver. J. Clin. Invest. 110:1483-1491. doi:10.1172/JCI200215880.
5. Bruning, J.C., et al. 1998. A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol. Cell. 2:559-569.
6. Fernandez, A.M., et al. 2006. Functional inactivation of the IGF-I and insulin receptors in skeletal muscle causes type 2 diabetes. Genes Dev. 15:1926-1934.
7. Bluher, M., et al. 2002. Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance. Dev. Cell. 3:25-38.
8. Bruning, J.C., et al. 2000. Role of brain insulin receptor in control of body weight and reproduction. Science. 289:2122-2125.
9. Okamoto, H., et al. 2004. Transgenic rescue of insulin receptor-deficient mice. J. Clin. Invest. 114:214-223. doi:10.1172/JCI200421645.
10. Obici, S., Zhang, B.B., Karkanias, G., and Rossetti, L. 2002. Hypothalamic insulin signaling is required for inhibition of glucose production. Nat. Med. 8:1376-1382.
11. Inoue, H., et al. 2004. Role of STAT-3 in regulation of hepatic gluconeogenic genes and of carbohydrate metabolism in vivo. Nat. Med. 10:168-174.
12. Inoue, H., et al. 2006. Role of hepatic STAT3 in brain insulin action on hepatic glucose production. Cell Metab. 3:267-275.
13. Souza, C.T., et al. 2006. Consumption of a fat-rich diet activates a proinflammatory response and induces insulin resistance in the hypothalamus. Endocrinology. 146:4192-4199.
14. Plum, L., Belgardt, B.F., and Brüning, J.C. 2006. Central insulin action in energy and glucose homeostasis. J. Clin. Invest. 116:1761-1766. doi:10.1172/JCI29063.
15. Withers, D.J., et al. 1998. Disruption of IRS-2 causes type 2 diabetes in mice. Nature. 391:900-904.
16. Kulkarni, R.N., et al. 1999. Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell. 96:329-339.
17. Abel, E.D., et al. 2001. Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature. 409:729-733.
18. Koishi, R., et al. 2002. Angptl3 regulates lipid metabolism in mice. Nat. Genet. 30:151-157.
19. Oike, Y., et al. 2005. Angiopoietin-related growth factor antagonizes obesity and insulin resistance. Nat. Med. 11:400-408.
20. Zimmers, T., et al. 2002. Induction of cachexia in mice by systemically administered myostatin. Science. 296:1486-1488.
21. Herman, M.A., and Kahn, B.B. 2006. Glucose transport and sensing in the maintenance of glucose homeostasis and metabolic harmony. J. Clin. Invest. 116:1767-1775. doi:10.1172/JCI29027.
22. Long, Y.C., and Zierath, J.R. 2006. AMP-activated protein kinase signaling in metabolic regulation. J. Clin. Invest. 116:1776-1783. doi:10.1172/JCI29044.
23. Kadowaki, T., et al. 2006 Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J. Clin. Invest. 116:1784-1792. doi:10.1172/JCI29126.
24. Weisberg, S.P., et al. 2003. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112:1796-1808. doi:10.1172/JCI200319246.
25. Xu, H., et al. 2003. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 112:1821-1830. doi:10.1172/JCI200319451.
26. Kanda, H., et al. 2006. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J. Clin. Invest. 116:1494-1505. doi:10.1172/JCI26498.
27. Weisberg, S.P., et al. 2006. CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J. Clin. Invest. 116:115-124. doi:10.1172/JCI24335.
28. Shoelson, S.E., Lee, J., and Goldfine, A.B. 2006. Inflammation and insulin resistance. J. Clin. Invest. 116:1793-1801. doi:10.1172/JCI29069.
29. Kim, J.K., et al. 2004. Inactivation of fatty acid transport protein 1 prevents fat-induced insulin resistance in skeletal muscle. J. Clin. Invest. 113:756-763. doi:10.1172/JCI200418917.
30. Maeda, K., et al. 2005. Adipocyte/macrophage fatty acid binding proteins control integrated metabolic responses in obesity and diabetes. Cell Metab. 1:107-119.
31. Itoh, Y., et al. 2003. Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40. Nature. 422:173-176.
32. Steneberg, P., Rubins, N., Bartoov-Shifman, R., Walker, M.D., and Edlund, H. 2005. The FFA receptor GPR40 links hyperinsulinemia, hepatic steatosis, and impaired glucose homeostasis in mouse. Cell Metab. 1:245-258.
33. Furukawa, S., et al. 2004. Increased oxidative stress in obesity and its impact on metabolic syndrome. J. Clin. Invest. 114:1752-1761. doi:10.1172/JCI200421625.
34. Ozcan, U., et al. 2004. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science. 306:457-461.
35. Kulkarni, R.N., et al. 2002. Beta-cell-specific deletion of the Igf1 receptor leads to hyperinsulinemia and glucose intolerance but does not alter beta-cell mass. Nat. Genet. 31:111-115.
36. Xuan, S., et al. 2002. Defective insulin secretion in pancreatic β cells lacking type 1 IGF receptor. J. Clin. Invest. 110:1011-1019. doi:10.1172/JCI200215276.
37. Ueki, K., et al. 2006. Total insulin and IGF-I resistance in pancreatic β cells causes overt diabetes. Nat. Genet. 38:583-588.
38. Hashimoto, N., et al. 2006. Ablation of PDK1 in pancreatic β cells induces diabetes as a result of loss of β-cell mass. Nat. Genet. 38:589-593.
39. Lowell, B.B., and Shulman, G.I. 2005. Mitochondrial dysfunction and type 2 diabetes. Science. 307:384-387.
40. Uchida, T., et al. 2005. Deletion of Cdkn1b gene ameliorates hyperglycemia by maintaining compensatory hyperinsulinemia in diabetic mice. Nat. Med. 11:175-182.
41. Prentki, M., and Nolan, C.J. 2006. Islet β cell failure in type 2 diabetes. J. Clin. Invest. 116:1802-1812. doi:10.1172/JCI29103.
42. Haffner, S.M., Lehto, S., Ronnemaa, T., Pyorala, K., and Laakso, M. 2003. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N. Engl. J. Med. 339:229-234.
43. Semenkovich, C.F. 2006. Insulin resistance and atherosclerosis. J. Clin. Invest. 116:1813-1822. doi:10.1172/JCI29024.
44. Baumgartl, J., et al. 2006. Myeloid lineage cell-restricted insulin resistance protects apolipoproteinE-deficient mice against atherosclerosis. Cell Metab. 3:247-256.
45. Han, S., et al. 2006. Macrophage insulin receptor deficiency increases ER stress-induced apoptosis and necrotic core formation in advanced atherosclerotic lesions. Cell Metab. 3:257-266.
46. DCCT/EDIC Study Research Group. 2005. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N. Engl. J. Med. 353:2643-2653.
47. Goldberg, I.J. 2004. Why does diabetes increase atherosclerosis? I don't know! J. Clin. Invest. 114:613-615. doi:10.1172/JCI200421645.